The THERADNET project is an innovative training network with the goal to integrate novel-emerging tumor-biological concepts into current standard-of-care to improve the outcome of radiotherapy-treated cancer patients. Approximately 50% of all cancer patients in Europe have an indication for radiotherapy at least once during the course of their disease, with an absolute number of patients steadily increasing assuming overall cancer rates remain unchanged. Advances in the modern radiotherapy could greatly increase chances of surviving cancer and improve the quality of life of treated patients.
THERADNET improves collaborative scientific action for researchers interested in radiotherapy. THERADNET covers a research program across 21 academic and non-academic, industry partners and brings together a multidisciplinary faculty of scientists and research-oriented clinicians who are well qualified and experienced in supervision.
THERADNET will prepare a new generation of highly competent and translational research-oriented early-stage researchers to expedite discovery and clinical translation in radiation research and oncology. With a view to finding novel strategies to cure cancer through radiotherapy, THERADNET will integrate novel radiobiological insights into clinical and technological approaches.
Latest News
The 3rd THERADNET workshop was held from the 13th to 15th of October 2021 in Dresden Germany and was organized...
Check out what THERADNET is all about in this article recently published in collaboration with EACR, one of our non-academic...
On April 20th, a webinar entitled “Digital presence in Twitter/Linkedin” was taught to the THERADNET fellows, with interested supervisors and...
The EU mid-term check meeting took place Virtually on February 22 nd 2021. The meeting featured contributions from THERADNET management, fellows...
On January 19 th , a webinar entitled “Digital presence” was taught to the THERADNET fellows, with interested supervisors and management being...